2023 Q4 Form 10-K Financial Statement
#000114036124016612 Filed on March 29, 2024
Income Statement
Concept | 2023 Q4 | 2023 | 2022 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $251.6K | $1.512M | $948.2K |
YoY Change | 12.86% | 59.52% | |
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $251.6K | $1.512M | $948.2K |
YoY Change | 12.86% | 59.52% | 266.03% |
Operating Profit | -$1.512M | -$948.2K | |
YoY Change | 59.52% | ||
Interest Expense | $520.5K | $5.299M | $3.383M |
YoY Change | -73.77% | 56.65% | |
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | $268.9K | $3.787M | $2.435M |
YoY Change | -84.73% | 55.53% | -1039.9% |
Income Tax | $0.00 | $0.00 | |
% Of Pretax Income | 0.0% | 0.0% | |
Net Earnings | $268.9K | $3.787M | $2.435M |
YoY Change | -84.73% | 55.53% | -1039.9% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | $0.03 | $0.23 | $0.08 |
COMMON SHARES | |||
Basic Shares Outstanding | |||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q4 | 2023 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $409.6K | $409.6K | $946.3K |
YoY Change | -56.71% | -56.71% | -34.3% |
Cash & Equivalents | $409.6K | ||
Short-Term Investments | |||
Other Short-Term Assets | $16.64K | $16.64K | $208.6K |
YoY Change | -92.02% | -15.99% | |
Inventory | |||
Prepaid Expenses | $16.64K | ||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $426.3K | $426.3K | $1.155M |
YoY Change | -63.09% | -63.09% | -31.61% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $44.29M | $44.29M | $238.0M |
YoY Change | -81.39% | -81.39% | 1.44% |
Other Assets | $0.00 | ||
YoY Change | -100.0% | ||
Total Long-Term Assets | $44.29M | $44.29M | $238.0M |
YoY Change | -81.39% | -81.39% | 1.36% |
TOTAL ASSETS | |||
Total Short-Term Assets | $426.3K | $426.3K | $1.155M |
Total Long-Term Assets | $44.29M | $44.29M | $238.0M |
Total Assets | $44.72M | $44.72M | $239.1M |
YoY Change | -81.3% | -81.3% | 1.12% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $42.05K | $42.05K | $2.100K |
YoY Change | 1902.38% | 1902.38% | -98.16% |
Accrued Expenses | $1.077M | $1.077M | $333.1K |
YoY Change | 223.35% | 223.35% | 5414.74% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $1.119M | $1.119M | $335.2K |
YoY Change | 233.87% | 233.87% | 179.05% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $4.600M | $4.600M | $4.600M |
YoY Change | 0.0% | 0.0% | 0.0% |
Other Long-Term Liabilities | $8.050M | $8.050M | $8.050M |
YoY Change | 0.0% | 0.0% | 0.0% |
Total Long-Term Liabilities | $12.65M | $12.65M | $12.65M |
YoY Change | 0.0% | 0.0% | 0.0% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.119M | $1.119M | $335.2K |
Total Long-Term Liabilities | $12.65M | $12.65M | $12.65M |
Total Liabilities | $13.77M | $13.77M | $12.99M |
YoY Change | 6.04% | 6.04% | 1.68% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$13.34M | ||
YoY Change | 12.78% | ||
Common Stock | |||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $30.95M | $30.95M | $226.2M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $44.72M | $44.72M | $239.1M |
YoY Change | -81.3% | -81.3% | 1.12% |
Cashflow Statement
Concept | 2023 Q4 | 2023 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $268.9K | $3.787M | $2.435M |
YoY Change | -84.73% | 55.53% | -1039.9% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$166.7K | -$536.7K | -$494.0K |
YoY Change | -11.15% | 8.64% | -17.3% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $1.850K | $199.0M | $0.00 |
YoY Change | -100.0% | ||
Cash From Investing Activities | $1.850K | $199.0M | $0.00 |
YoY Change | -100.0% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | -$1.850K | -$199.0M | $0.00 |
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -1.850K | -199.0M | 0.000 |
YoY Change | -100.0% | ||
NET CHANGE | |||
Cash From Operating Activities | -166.7K | -536.7K | -494.0K |
Cash From Investing Activities | 1.850K | 199.0M | 0.000 |
Cash From Financing Activities | -1.850K | -199.0M | 0.000 |
Net Change In Cash | -166.7K | -536.7K | -494.0K |
YoY Change | -11.15% | 8.64% | -134.3% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$166.7K | -$536.7K | -$494.0K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-10882188 | |
CY2023Q4 | us-gaap |
Assets
Assets
|
44716401 | |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
42046 | |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1077056 | |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1119102 | |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
13769102 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
0 | |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
44716401 | |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-948157 | |
CY2022Q4 | us-gaap |
Cash
Cash
|
946299 | |
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
16640 | |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
426283 | |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1154847 | |
CY2023Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
44290118 | |
CY2022Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
237982862 | |
CY2022Q4 | us-gaap |
Assets
Assets
|
239137709 | |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2100 | |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
333092 | |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
335192 | |
CY2023Q4 | dpcs |
Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
|
8050000 | |
CY2022Q4 | dpcs |
Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
|
8050000 | |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
12985192 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
0 | |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-13343394 | |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-11830920 | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13342819 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-11830345 | |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
239137709 | |
CY2023 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1512474 | |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
948157 | |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1512474 | |
CY2023 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
5299109 | |
CY2022 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
3382862 | |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
3786635 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2434705 | |
CY2022 | dpcs |
Redeemable Ordinary Shares Accretion To Redemption Value
RedeemableOrdinarySharesAccretionToRedemptionValue
|
-3382862 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-11830345 | |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
3786635 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2434705 | |
CY2023 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
5299109 | |
CY2022 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
3382862 | |
CY2023 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-191908 | |
CY2022 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-25452 | |
CY2022 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-213631 | |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
39946 | |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-111977 | |
CY2023 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
743964 | |
CY2022 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
327051 | |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-536656 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-494000 | |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
198991853 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-536656 | |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-494000 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
946299 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1440299 | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
409643 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
946299 | |
CY2023 | dpcs |
Accretion Of Ordinary Shares To Redemption Value
AccretionOfOrdinarySharesToRedemptionValue
|
5299109 | |
CY2022 | dpcs |
Accretion Of Ordinary Shares To Redemption Value
AccretionOfOrdinarySharesToRedemptionValue
|
3382862 | |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="text-align: justify; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Use of Estimates</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"> </div> <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"> </div> <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimates, could change in the near term. Accordingly, the actual results could differ significantly from those estimates.</div> | |
CY2023 | us-gaap |
Derivatives Embedded Derivatives
DerivativesEmbeddedDerivatives
|
<div style="text-align: justify; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Sponsor Loan</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"> </div> <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"><span style="letter-spacing: normal; text-indent: 0px; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">When the Company issues convertible debt it first evaluates the balance sheet classification of the convertible instrument in its entirety to determine whether the instrument should be classified as a liability under ASC 480 and second whether the conversion feature should be accounted for separately from the host instrument. A conversion feature of a convertible debt instrument or certain convertible preferred stock would be separated from the convertible instrument and classified as a derivative liability if the conversion feature, were it a stand-alone instrument, meets the definition of an “embedded derivative” as defined in ASC 815. Generally, characteristics that require derivative treatment include, among others, when the conversion feature is not indexed to the Company’s equity, as defined in ASC 815-40, or when it must be settled either in cash or by issuing stock that is readily convertible to cash. When a conversion feature meets the definition of an embedded derivative, it would be separated from the host instrument and classified as a derivative liability carried on the balance sheet at fair value, with any changes in its fair value recognized currently in the statement of operations. The Sponsor Loan has a conversion feature that allows for converting the loan into warrants. The Company performed an evaluation as outlined and determined that it qualifies for exemption as an equity instrument and is not bifurcated.</span></div> | |
CY2023 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001857803 | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
00-0000000 | |
CY2022Q4 | us-gaap |
Notes Payable Noncurrent Related Party Type Extensible Enumeration
NotesPayableNoncurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#RelatedPartyMember | |
CY2023Q4 | us-gaap |
Notes Payable Noncurrent Related Party Type Extensible Enumeration
NotesPayableNoncurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#RelatedPartyMember | |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
688 | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2023 | dei |
Document Type
DocumentType
|
10-K | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-12-31 | |
CY2023 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
001-41041 | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
DP CAP ACQUISITION CORP I | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
E9 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
341 Newbury St, | |
CY2023 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
6th Floor | |
CY2023 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
02115 | |
CY2023 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Boston | |
CY2023 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
MA | |
CY2023 | dei |
City Area Code
CityAreaCode
|
617 | |
CY2023 | dei |
Local Phone Number
LocalPhoneNumber
|
874-5152 | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2023 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2023 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
true | |
CY2023Q2 | dei |
Entity Public Float
EntityPublicFloat
|
42826691 | |
CY2023Q4 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2023Q4 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2023Q4 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2023Q4 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2023 | dei |
Auditor Name
AuditorName
|
Marcum LLP | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
New York | |
CY2023Q4 | us-gaap |
Cash
Cash
|
409643 | |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
208548 | |
CY2023Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
4600000 | |
CY2022Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
4600000 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-11830345 | |
CY2023 | dpcs |
Adjustment To Additional Paid In Capital Capital Contribution By Sponsor
AdjustmentToAdditionalPaidInCapitalCapitalContributionBySponsor
|
2791710 | |
CY2023 | dpcs |
Adjustment To Additional Paid In Capital Cost Of Raising Capital
AdjustmentToAdditionalPaidInCapitalCostOfRaisingCapital
|
2791710 | |
CY2023 | dpcs |
Redeemable Ordinary Shares Accretion To Redemption Value
RedeemableOrdinarySharesAccretionToRedemptionValue
|
-5299109 | |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
3786635 | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13342819 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2434705 | |
CY2023 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
0 | |
CY2023 | dpcs |
Proceeds From Cash Withdrawal From Trust Account
ProceedsFromCashWithdrawalFromTrustAccount
|
198991853 | |
CY2022 | dpcs |
Proceeds From Cash Withdrawal From Trust Account
ProceedsFromCashWithdrawalFromTrustAccount
|
0 | |
CY2023 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
198991853 | |
CY2022 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-198991853 | |
CY2023 | dpcs |
Capital Contribution From Sponsor
CapitalContributionFromSponsor
|
2791710 | |
CY2022 | dpcs |
Capital Contribution From Sponsor
CapitalContributionFromSponsor
|
0 | |
CY2023 | dpcs |
Offering Costs Associated With Non Redemption Agreement
OfferingCostsAssociatedWithNonRedemptionAgreement
|
2791710 | |
CY2022 | dpcs |
Offering Costs Associated With Non Redemption Agreement
OfferingCostsAssociatedWithNonRedemptionAgreement
|
0 | |
CY2021Q4 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
234600000 | |
dpcs |
Cash Deposited In Trust Account Per Unit
CashDepositedInTrustAccountPerUnit
|
10.2 | ||
dpcs |
Cash Deposited In Trust Account Per Unit
CashDepositedInTrustAccountPerUnit
|
10.2 | ||
CY2023 | dpcs |
Percentage Of Public Shares That Would Not Be Redeemed If Business Combination Is Not Completed Within Initial Combination Period
PercentageOfPublicSharesThatWouldNotBeRedeemedIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod
|
1 | |
dpcs |
Cash Deposited In Trust Account Per Unit
CashDepositedInTrustAccountPerUnit
|
10.2 | ||
dpcs |
Cash Deposited In Trust Account Per Unit
CashDepositedInTrustAccountPerUnit
|
10.2 | ||
CY2023Q4 | dpcs |
Working Capital Deficit
WorkingCapitalDeficit
|
-692819 | |
CY2023Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | |
CY2022Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | |
CY2023Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2023Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2021Q4 | dpcs |
Payments For Underwriting Discount Per Unit
PaymentsForUnderwritingDiscountPerUnit
|
0.2 | |
CY2021Q4 | us-gaap |
Payments For Underwriting Expense
PaymentsForUnderwritingExpense
|
4600000 | |
CY2021Q4 | dpcs |
Deferred Underwriting Fee Per Unit
DeferredUnderwritingFeePerUnit
|
0.35 | |
CY2021Q4 | dpcs |
Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
|
8050000 | |
us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
230000000 | ||
us-gaap |
Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
|
24239238 | ||
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2023 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
|
0 | |
CY2022 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
|
0 | |
CY2022 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
|
0 | |
CY2023 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
|
0 |